INVO Fertility Receives Nasdaq Deficiency Notice for Missing April 15 10-K
INVO Fertility received a Nasdaq deficiency notice on April 23 for missing its April 15, 2026 10-K filing covering the year ended December 31, 2025. The company has 60 days to submit a compliance plan and could secure up to 180 additional days if Nasdaq approves.
1. Nasdaq Deficiency Notice
On April 23, INVO Fertility received written notice from Nasdaq Listing Qualifications for failing to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was due April 15, 2026. The company's shares continue trading on Nasdaq pending compliance resolution.
2. Underlying Accounting Complexities
The filing delay stems from additional review of complex accounting matters including the tax provision, certain warrant positions, and variable interest entity accounting. Management indicates these issues require extended analysis to ensure accuracy before finalizing the report.
3. Compliance Plan and Timeline
Under Nasdaq Listing Rule 5810(c)(2)(F), INVO has 60 calendar days from the notice date to submit a compliance plan. If accepted, Nasdaq may grant up to 180 days from the original filing deadline to complete the Form 10-K; rejection would trigger an appeal process before a Nasdaq Hearings Panel.